Mersana Therapeutics, Inc.
USD29.08
+0.00 (+0.00%)
CEO
Martin H. Huber
IPO Date
2017-06-28
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$28.78
Prev. Close
$29.08
Day Low
$28.78
Day High
$29.08
52W Low
$5.21
52W High
$30.39
Market Cap
$0.15B
Volume
0.62M
| -1.6 |
| 31 Dec 2022 | FY | 100.0% | -768.3% | -221.8% | -61.1% | 0.39 | 3.49 | -2.7 |
| 31 Dec 2021 | FY | 100.0% | -395488.4% | -139.7% | -82.5% | 0.31 | 3.97 | -2.6 |
| 31 Dec 2020 | FY | -7996.1% | -10633.5% | -38.6% | -32.2% | 0.07 | 8.62 | -18.6 |
| 31 Dec 2019 | FY | 100.0% | -67.0% | -36.0% | -26.2% | 0.10 | 4.21 | -8.8 |
| 31 Dec 2018 | FY | -465.6% | -606.5% | -730.6% | -81.9% | 0.00 | 1.01 | -1.5 |
| 31 Dec 2017 | FY | 94.7% | -220.6% | -55.3% | -29.6% | 0.00 | 3.69 | -9.6 |
| 31 Dec 2016 | FY | -27.2% | -54.4% | 24.6% | -13.0% | 0.00 | 3.60 | -17.9 |
| 31 Dec 2015 | FY | -106.1% | -158.6% | 38.5% | -114.0% | 0.00 | 1.19 | -14.9 |
| -0.4 |
| 31 Mar 2025 | Q1 | 100.0% | -875.9% | 78.1% | -21.4% | -0.80 | 1.83 | -0.4 |
| 31 Dec 2024 | Q4 | 100.0% | -86.3% | 148.5% | -9.8% | -3.01 | 2.19 | -3.1 |
| 30 Sept 2024 | Q3 | 100.0% | -91.3% | -1096.4% | -6.8% | 30.03 | 2.35 | -5.0 |
| 30 Jun 2024 | Q2 | 100.0% | -1058.4% | -288.0% | -13.5% | 4.27 | 2.72 | -2.5 |
| 31 Mar 2024 | Q1 | 100.0% | -208.8% | -69.0% | -9.7% | 1.18 | 3.51 | -6.9 |
| 31 Dec 2023 | Q4 | 95.8% | -182.6% | -53.0% | -8.6% | 0.92 | 3.36 | -3.6 |
| 30 Sept 2023 | Q3 | 94.5% | -541.1% | -79.8% | -15.8% | 0.66 | 3.68 | -0.9 |
| 30 Jun 2023 | Q2 | 97.0% | -509.7% | -60.5% | -17.5% | 0.39 | 3.97 | -1.8 |